They observed a high NOX2 plasma concentration in Intensive Care Unit (ICU) COVID-19 patients and even higher in thrombosis cases, which implies NOX2 rates relate to a poor diagnosis (Violi et al., 2020). The gene discussed is CYBB; the disease is COVID-19.